AbbVie - 5 Year Stock Price History | ABBV

Historical daily share price chart and data for AbbVie since 2013 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AbbVie as of November 16, 2018 is 91.53.
AbbVie Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 97.6881 95.7421 120.7271 77.8500 91.5300 -2.72%
2017 72.2922 58.5607 95.5475 56.8887 94.0881 60.13%
2016 56.1176 52.0041 62.6502 46.7144 58.7578 9.88%
2015 55.2983 57.5628 63.6950 43.5730 53.4755 -6.46%
2014 47.8856 43.9710 60.9000 39.9325 57.1696 27.97%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $137.681B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
Eli Lilly (LLY) United States $120.583B 21.20
Sanofi (SNY) France $113.115B 14.01
Novo Nordisk (NVO) Denmark $107.931B 17.53
AstraZeneca (AZN) United Kingdom $103.013B 12.79
GlaxoSmithKline (GSK) United Kingdom $100.041B 13.45
Bristol-Myers Squibb (BMY) United States $88.253B 14.53